Equities

Jubilant Pharmova Ltd

JUBLPHARMA:NSI

Jubilant Pharmova Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)1,138.50
  • Today's Change3.00 / 0.26%
  • Shares traded76.01k
  • 1 Year change+171.07%
  • Beta1.8848
Data delayed at least 15 minutes, as of Nov 22 2024 10:01 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments9,53910,1089,803
Total Receivables, Net12,70912,12511,469
Total Inventory13,03814,21512,861
Prepaid expenses910900834
Other current assets, total2,565277126
Total current assets38,76137,62435,092
Property, plant & equipment, net36,87133,65127,911
Goodwill, net24,63924,28622,428
Intangibles, net10,4339,5109,263
Long term investments4222,5642,386
Note receivable - long term1,7551,4641,026
Other long term assets172161160
Total assets115,485111,56699,909
LIABILITIES
Accounts payable8,5638,2135,677
Accrued expenses2,6592,2872,482
Notes payable/short-term debt1,9652,583640
Current portion long-term debt/capital leases1,0269494,516
Other current liabilities, total4,6773,6922,601
Total current liabilities18,89017,72415,916
Total long term debt33,64933,23626,764
Total debt36,64036,76831,920
Deferred income tax2,1083,0623,030
Minority interest(128)(75)(22)
Other liabilities, total6,6273,6261,035
Total liabilities61,14657,57446,723
SHAREHOLDERS EQUITY
Common stock159159159
Additional paid-in capital--0.020.02
Retained earnings (accumulated deficit)45,65053,83453,026
Treasury stock - common(1)(0.21)(0.11)
Unrealized gain (loss)------
Other equity, total8,531----
Total equity54,33953,99353,186
Total liabilities & shareholders' equity115,485111,56699,909
Total common shares outstanding158159159
Treasury shares - common primary issue0.930.210.11
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.